advances-in-protein-chemistry

Antimicrob Agents Chemother 49: 3302-3310.
141. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, et al. (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent
kinase 2. Nature 380: 548-550.
142. von Moos E, Ben RN (2005) Recent advances in the synthesis of C-linked glycoconjugates. Curr Top Med Chem 5: 1351-1361.
143. Engel JB, Schally AV, Halmos G, Baker B, Nagy A, et al. (2005) Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human
breast cancers with a low induction of multi-drug resistance proteins. Endocr Relat Cancer 12: 999-1009.
144. Keller G, Schally AV, Nagy A, Baker B, Halmos G, et al. (2006) Effective therapy of experimental human malignant melanomas with a targeted
cytotoxic somatostatin analogue without induction of multi-drug resistance proteins. Int J Oncol 28: 1507-1513.
145. Sun LC, Coy DH (2011) Somatostatin receptor-targeted anti-cancer therapy. Curr Drug Deliv 8: 2-10.
146. Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes.
J Biol Chem 269: 10444-10450.
147. Vivès E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates
in the cell nucleus. J Biol Chem 272: 16010-16017.
148. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, et al. (2000) The design, synthesis, and evaluation of molecules that enable or
enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97: 13003-13008.
149. Madani F, Lindberg S, Langel U, Futaki S, Gräslund A (2011) Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys 2011: 414729.
150. Engel JB, Schally AV, Halmos G, Baker B, Nagy A, et al. (2005) Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human
breast cancers with a low induction of multi-drug resistance proteins. Endocr Relat Cancer 12: 999-1009.
151. Keller G, Schally AV, Nagy A, Baker B, Halmos G, et al. (2006) Effective therapy of experimental human malignant melanomas with a targeted
cytotoxic somatostatin analogue without induction of multi-drug resistance proteins. Int J Oncol 28: 1507-1513.
152. Silva AL, Rosalia RA, Sazak A, Carstens MG, Ossendorp F, et al. (2013) Optimization of encapsulation of a synthetic long peptide in PLGA
nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation. Eur J Pharm Biopharm 83: 338-345.
153. Dombu CY, Betbeder D (2013) Airway delivery of peptides and proteins using nanoparticles. Biomaterials 34: 516-525.
154. Marx V (2005) Watching Peptide Drugs Grow up. C&EN 83: 17-24.
OMICS Group eBooks
015